Synthesis and biological evaluation of all eight stereoisomers of DPP-IV inhibitor saxagliptin

Abstract

All eight stereoisomers of saxagliptin have been synthesized and evaluated for their inhibitory activity against DPP-IV. It was unambiguously confirmed that the configuration of saxagliptin was critical to potent inhibition of DPP-IV. Docking study was performed to elucidate the configuration-activity relationship of saxagliptin stereoisomers. Tyr662 and Tyr470 have been suggested as the key residues of DPP-IV interacting with the inhibitors. This work provides valuable information for further inhibitor design against DPP-IV.

Keywords: Configuration–activity relationship; DPP-IV inhibitors; Saxagliptin; Stereoisomers; Synthesis.